Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Clarithromycin measurement |
Component |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin poisoning |
Causative agent (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental clarithromycin poisoning (disorder) |
Causative agent (attribute) |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional clarithromycin poisoning |
Causative agent (attribute) |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la clarithromycine d'intention indéterminée |
Causative agent (attribute) |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin adverse reaction |
Causative agent (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to clarithromycin (finding) |
Causative agent (attribute) |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin overdose (disorder) |
Causative agent (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental clarithromycin overdose |
Causative agent (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional clarithromycin overdose (disorder) |
Causative agent (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de clarithromycine d'intention indéterminée |
Causative agent (attribute) |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin 125mg/5mL pediatric suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely clarithromycin 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely clarithromycin 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin 250 mg granules for oral suspension sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin 250mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Biaxin for oral 125mg/5ml pediatric suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing clarithromycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin 500mg tablet and lansoprazole 30mg capsule and amoxycillin 500mg capsule pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin 250mg/5mL pediatric suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin tablet+lansoprazole capsule+metronidazole tablet 500mg/30mg/400mg pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin 1000mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental clarithromycin poisoning (disorder) |
Causative agent (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional clarithromycin poisoning |
Causative agent (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing clarithromycin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to clarithromycin (finding) |
Causative agent (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
14-hydroxyclarithromycin (substance) |
Is a |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin 250 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clarithromycin 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clarithromycin 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clarithromycin 1 gram/1 each prolonged-release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin 500 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin 500 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin 250 mg oral tablet |
Has precise active ingredient |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clarithromycin 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clarithromycin 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clarithromycin 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin 250 mg granules for oral suspension sachet |
Has basis of strength substance (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin 250 mg granules for oral suspension sachet |
Has precise active ingredient |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin 50 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin 50 mg/mL oral suspension |
Has precise active ingredient |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
14-hydroxyclarithromycin (substance) |
Is modification of (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin 25 mg/mL oral suspension |
Has precise active ingredient |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin 25 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only clarithromycin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clarithromycin 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clarithromycin 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin citrate (substance) |
Is modification of (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clarithromycin (as clarithromycin citrate) 500 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely clarithromycin (as clarithromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clarithromycin lactobionate (substance) |
Is modification of (attribute) |
True |
Clarithromycin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|